We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
+$76.9M
Cap. Flow
+$113M
Cap. Flow %
5.39%
Top 10 Hldgs %
44.54%
Holding
114
New
28
Increased
33
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$38.4M
2
RVMD icon
Revolution Medicines
RVMD
+$30.3M
3
ROIV icon
Roivant Sciences
ROIV
+$29.5M
4
BSX icon
Boston Scientific
BSX
+$26M
5
MRK icon
Merck
MRK
+$20.2M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$64.8M
2
ISRG icon
Intuitive Surgical
ISRG
+$37.9M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$31.2M
4
PEN icon
Penumbra
PEN
+$31.1M
5
TFX icon
Teleflex
TFX
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 90.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
26
Neurocrine Biosciences
NBIX
$16.7B
$19.8M 0.95%
150,000
– –
GKOS icon
27
Glaukos
GKOS
$10.7B
$18.8M 0.9%
175,000
-150,000
-46% -$16.9M
ARWR icon
28
Arrowhead Research
ARWR
$12.5B
$18.8M 0.9%
300,000
+200,000
+200% +$12.7M
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$132B
$17.9M 0.85%
+40,000
New +$18.7M
ORIC icon
30
Oric Pharmaceuticals
ORIC
$1.41B
$17.7M 0.85%
1,400,000
+200,000
+17% +$2.27M
ALMS
31
Alumis Inc
ALMS
$3.51B
$17.6M 0.84%
+800,000
New +$20M
FMS icon
32
Fresenius Medical Care
FMS
$12.9B
$17.5M 0.84%
775,000
+125,000
+19% +$2.87M
ISRG icon
33
Intuitive Surgical
ISRG
$138B
$16.1M 0.77%
35,000
-75,000
-68% -$37.9M
QURE icon
34
uniQure
QURE
$3.23B
$14.7M 0.7%
900,000
– –
TARS icon
35
Tarsus Pharmaceuticals
TARS
$2.95B
$14M 0.67%
200,000
– –
GILD icon
36
Gilead Sciences
GILD
$165B
$13.9M 0.67%
+100,000
New +$14M
LLY icon
37
Eli Lilly
LLY
$1.1T
$13.8M 0.66%
15,000
-5,000
-25% -$5.07M
EW icon
38
Edwards Lifesciences
EW
$53.1B
$13.6M 0.65%
170,000
-155,000
-48% -$12.8M
MLYS icon
39
CALL
Mineralys Therapeutics
MLYS
$2.4B
$13.5M 0.65%
500,000
+250,000
+100% +$7.33M
COGT icon
40
Cogent Biosciences
COGT
$7.1B
$13.5M 0.64%
+350,000
New +$12.9M
ELAN icon
41
Elanco Animal Health
ELAN
$11.1B
$13.2M 0.63%
550,000
+300,000
+120% +$7.33M
MDGL icon
42
Madrigal Pharmaceuticals
MDGL
$11.9B
$13.1M 0.63%
+25,000
New +$11.9M
PRAX icon
43
Praxis Precision Medicines
PRAX
$10.2B
$12.9M 0.62%
40,000
– –
DNTH icon
44
Dianthus Therapeutics
DNTH
$6.2B
$12.6M 0.6%
150,000
-125,000
-45% -$7.24M
RGNX icon
45
Regenxbio
RGNX
$694M
$12.6M 0.6%
1,500,000
+300,000
+25% +$3.15M
DGX icon
46
Quest Diagnostics
DGX
$26.2B
$11.8M 0.56%
60,000
-15,000
-20% -$2.91M
XENE icon
47
Xenon Pharmaceuticals
XENE
$6.17B
$11.6M 0.56%
+200,000
New +$9.22M
ERAS icon
48
Erasca
ERAS
$6.34B
$11.3M 0.54%
+700,000
New +$8.27M
ANRO icon
49
Alto Neuroscience
ANRO
$1.1B
$11.2M 0.54%
500,000
+125,000
+33% +$2.32M
BIIB icon
50
Biogen
BIIB
$30.6B
$11M 0.53%
60,000
-40,000
-40% -$7.37M
1
2
3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Integral Health Asset Management held 114 positions worth $2.09B, up 3.8% from $2.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management deployed $113M of net new capital in Q1 2026, opening 28 new positions and adding to 33 existing holdings. Its largest new stake was Alumis Inc: 800,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $37.9M trimmed.

  • Integral Health Asset Management's largest Q1 2026 buy was Alumis Inc: 800,000 shares worth $17.6M.
  • Integral Health Asset Management added most to Insmed in Q1 2026, an estimated $38.4M increase.
  • Integral Health Asset Management's biggest Q1 2026 reduction was Intuitive Surgical, cutting an estimated $37.9M.
  • Integral Health Asset Management fully exited Medtronic in Q1 2026, selling an estimated $64.8M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.09B portfolio in Q1 2026.
  • Integral Health Asset Management opened 28 new positions and closed 24 in Q1 2026.
  • Integral Health Asset Management's portfolio value rose 3.8% quarter-over-quarter to $2.09B.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.